Developer docs
API playgroundTry for free, no card

Search company profiles

Inpharmatis

Full company profile

uuid000647y

Namestring
Inpharmatis
Legal namestring
Inpharmatis SIA
Websiteurl
inpharmatis.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Inpharmatis is a privately held international consulting group headquartered in Riga, Latvia, providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, training, and patient information leaflet readability testing services to pharmaceutical, medical device, food supplement, cosmetic, and biotechnology companies. The firm operates across more than 70 countries spanning the EU, CIS, EAEU, Baltic, Caucasus, and Central Asian regulatory regimes, supported by offices in Riga, Tashkent (a representative office established in 2021 and an LLC legal entity opened in November 2024), and Kiev, with a multidisciplinary team of doctors, pharmacists, chemists, and PhD holders working in more than 20 languages. Its proprietary product, PRUDENTA, is a cloud-based pharmacovigilance platform with artificial intelligence integration that supports local medical literature monitoring, validated search workflows, and electronic access to published articles for adverse drug reaction surveillance, and was developed with funding from an EU Commission grant (Agreement No. 828084).

The company generates revenue primarily through project-based professional services engagements and multi-year retainer contracts priced on scope and geographic coverage, with a secondary subscription/usage-based revenue stream from PRUDENTA. Go-to-market is enterprise field sales supported by active participation in major industry conferences (CPHI, RAPS, ISPE, TOPRA, DIA) and direct engagement via phone, email, and industry webinars. The firm has built an authorized partnership portfolio that includes LORENZ Life Sciences (eCTD and RIM solutions across 15 countries), DOT Compliance (AI-powered eQMS), and EPISTA Life Science (computer system validation software), allowing it to resell complementary technology alongside its consulting engagements. Inpharmatis reports 5,500+ completed projects and 500+ customers cumulatively, with no public revenue, funding, or valuation disclosure.

Short descriptiontext

Inpharmatis is a Latvia-based international consulting group providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, and PIL readability testing to pharmaceutical, medical device, food supplement, cosmetic, and biotech companies across the EU, CIS, and EAEU.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRiga, Latvia
HQ citystring
Riga
HQ countrystring
Latvia
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, pharmacovigilance services, GMP GDP audits, eCTD publishing, drug registration services
Industry2 codes
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Pharmaceutical Regulatory Consulting
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model7 records
1Regulatory Affairs Consulting Services
TypeProfessional Services
Description

Professional consulting services for pharmaceutical product registration, dossier preparation, regulatory strategy development, and lifecycle management across EU, CIS, and EAEU markets. Revenue generated through project-based engagements and retainer arrangements.

inpharmatis.com
2Pharmacovigilance Services
TypeProfessional Services
Description

Full scope of pharmacovigilance consulting including QPPV/LPPV services, PSMF creation, case processing, literature monitoring, and signal management. Provided to pharmaceutical companies operating in regulated markets.

inpharmatis.com
3Quality Management & GMP/GDP Audits
TypeProfessional Services
Description

Consulting services for GMP/GDP compliance including pre-audits, inspection support, and QMS development. Sale of ready-made GMP audit reports of API manufacturers.

inpharmatis.com
4eCTD Publishing Services
TypeProfessional Services
Description

Electronic submission management and publishing services for regulatory dossiers. Handles dossier compilation, formatting, lifecycle management, and submission through regulatory portals.

inpharmatis.com
5Training Services
TypeProfessional Services
Description

In-house and customized training programs for regulatory affairs, pharmacovigilance, and GMP/GDP compliance. Offered as off-the-shelf, tailored, or bespoke programs.

inpharmatis.com
6PIL Readability User Testing
TypeProfessional Services
Description

User testing services for patient information leaflets according to EAEU requirements, including bridging studies and GAP analysis.

inpharmatis.com
7PRUDENTA Software Solution
TypeSubscription Recurring
Description

Cloud-based AI-powered solution for monitoring adverse drug reactions in local medical literature. Subscription or usage-based access to the platform.

inpharmatis.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Services are priced based on project scope, complexity, and geographic coverage. Quote-based engagement model.

inpharmatis.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1PRUDENTA
Description

Cloud-based pharmacovigilance solution for monitoring adverse drug reactions in local medical literature with AI integration and validated workflow processes.

inpharmatis.com
Core offering1 text field

Inpharmatis is an international consulting group providing full-cycle pharmaceutical regulatory services including Regulatory Affairs, Pharmacovigilance, GMP/GDP audits, eCTD publishing, and training for pharmaceutical, biotech, medical device, food supplement, and cosmetic companies across EU, CIS, and EAEU markets. The company also develops PRUDENTA, a proprietary cloud-based AI-powered pharmacovigilance solution for local medical literature monitoring, funded by European Commission Grant Agreement No. 828084.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 5,500+ successfully completed projects
+3 more records
Product overview1 text field

Inpharmatis is an international consulting group providing full-cycle services in Regulatory Affairs, Pharmacovigilance, Quality Management (GMP/GDP), and electronic solutions for the Life Science industry. The company's service portfolio includes: Regulatory Affairs Services covering EU, CIS, and EAEU markets; Pharmacovigilance Services with QPPV/LPPV provision and literature monitoring; Quality Management & GMP/GDP Audits; eCTD Publishing Service; Training Programs; and PIL Readability User Testing. The company also offers PRUDENTA, a proprietary cloud-based pharmacovigilance solution with AI integration for local literature monitoring. Through strategic partnerships, Inpharmatis provides access to LORENZ eCTD/RIM solutions (docuBridge, drugTrack, eValidator), DOT Compliance AI-powered eQMS, and EPISTA validation software.

Product and service7 records
1Regulatory Affairs Services
CategoryRegulatory Affairs Consulting
Description

Comprehensive consultancy services for registration of medicines, medical devices, food supplements, and cosmetics across Europe, CIS, and EAEU regions, including project management, regulatory strategy development, dossier preparation, and SmPC/PIL development for pharmaceutical companies.

2Pharmacovigilance Services
CategoryPharmacovigilance Consulting
Description

Full scope of pharmacovigilance consulting services including QPPV/LPPV provision, PV system creation and management, auditing, PSUR/RMP reports, signal management, and local medical literature monitoring in EU, CIS, and EAEU regions for pharmaceutical companies.

3Quality Management & GMP/GDP Audits
CategoryQuality Management Consulting
Description

Quality management consulting services including QMS development, GMP/GDP consulting, QA services, QP services, GMP/GDP audits of manufacturers, and preparation for EU/EAEU inspections for pharmaceutical manufacturers.

4eCTD Publishing Service
CategoryRegulatory Publishing Services
Description

Regulatory eCTD submission management and publishing services supporting full product lifecycle from initial submission to renewals and variations, with submissions handled to EMA, FDA, Swissmedic, Ukraine, MHRA, and EAEU.

5Training Services
CategoryProfessional Training
Description

In-house regulatory affairs, pharmacovigilance, and GMP/GDP training programs offered in off-the-shelf, tailored, and bespoke formats for pharmaceutical industry professionals.

6PIL Readability User Testing
CategoryRegulatory Testing Services
Description

Patient Information Leaflet (PIL) readability testing according to EAEU requirements with guaranteed acceptance rates, including GAP analysis, bridging studies, and translation services for pharmaceutical companies.

7PRUDENTA Pharmacovigilance Platform
CategoryPharmacovigilance Software
Description

Cloud-based AI-powered pharmacovigilance solution for monitoring adverse drug reactions in local medical literature, with electronic access to published articles, validated workflow processes, and quality control checks for pharmaceutical companies.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

Official LORENZ Partner authorised to promote and implement LORENZ eCTD and Regulatory Information Management (RIM) solutions including docuBridge, drugTrack, and eValidator in Turkey, Ukraine, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Uzbekistan, Turkmenistan, Mongolia, Latvia, Lithuania, and Estonia. LORENZ develops leading RIM solutions for Life Sciences since 1989 with over 1800 installations in 48 countries.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with DOT Compliance - the first ready-to-use AI-powered eQMS for Life Science Industry. Provides cloud-based quality management system solutions for rapid implementation and quality insights.

Strategic tierSupportingTypeTechnology or Integration
Description

Partnership with EPISTA Life Science for software solutions that automate and accelerate validation of computer systems in the pharmaceutical industry.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

PharmaLex is a larger, established regulatory affairs, pharmacovigilance, and quality management consultancy serving pharma and biotech globally. Direct overlap with Inpharmatis's full-service regulatory + PV + GMP offering, but at significantly greater scale and broader geographic footprint; recently acquired by Cencora, increasing competitive intensity.

TypeDirect peer
Description

Arriello is a regulatory affairs and pharmacovigilance consultancy with strong EU and emerging-markets presence, offering dossier preparation, local QPPV services, and PV operations. Closely comparable to Inpharmatis in service mix, customer profile (mid-market pharma), and multi-jurisdictional regulatory coverage.

TypeEmerging player
Description

PharmEng Technology provides GMP compliance, validation, and regulatory consulting to pharma manufacturers. Overlaps with Inpharmatis's quality management and GMP/GDP audit services, particularly for API manufacturers seeking international registrations.

TypeOthers
Description

DOT Compliance provides AI-powered electronic Quality Management System (eQMS) software for the life sciences industry. Technology partner of Inpharmatis for QMS implementations, with partial competitive overlap on quality management consulting.

TypeDirect peer
Description

Apcer provides pharmacovigilance, regulatory affairs, and quality compliance services to pharma and medical device companies globally. Direct overlap with Inpharmatis in PV operations, regulatory consulting, and quality management services.

6CROMSOURCE
TypeBroad incumbent
Description

CROMSOURCE is an established mid-sized CRO providing clinical, regulatory, and pharmacovigilance services across Europe and emerging markets. Comparable EU + CIS service mix to Inpharmatis but with broader clinical CRO capabilities and larger headcount.

TypeOthers
Description

LORENZ is a software vendor of eCTD and Regulatory Information Management (RIM) solutions used across life sciences. Inpharmatis is an authorized implementation partner for LORENZ, so this is a technology partner rather than competitor, but adjacent in the regulatory workflow Inpharmatis serves.

TypeDirect peer
Description

Pharmexon is a regulatory affairs and pharmacovigilance consultancy supporting pharma clients across EU and international markets. Closely comparable boutique regulatory services model and similar target customer profile to Inpharmatis.

TypeDirect peer
Description

Regulis is a regulatory affairs and pharmacovigilance consultancy providing EU and international market access services to pharma and biotech clients. Direct peer in service scope (registration, PV, QPPV) and customer segment.

10Diapharm
TypeDirect peer
Description

Diapharm is a regulatory affairs, quality management, and pharmacovigilance consultancy focused on pharma, medical devices, and consumer health. Comparable boutique scale and EU-centric service portfolio with similar clientele to Inpharmatis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inpharmatis

Pharmaceutical Regulatory Consultinginpharmatis.com

Inpharmatis is a Latvia-based international consulting group providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, and PIL readability testing to pharmaceutical, medical device, food supplement, cosmetic, and biotech companies across the EU, CIS, and EAEU.

What Inpharmatis does

Inpharmatis is a privately held international consulting group headquartered in Riga, Latvia, providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, training, and patient information leaflet readability testing services to pharmaceutical, medical device, food supplement, cosmetic, and biotechnology companies. The firm operates across more than 70 countries spanning the EU, CIS, EAEU, Baltic, Caucasus, and Central Asian regulatory regimes, supported by offices in Riga, Tashkent (a representative office established in 2021 and an LLC legal entity opened in November 2024), and Kiev, with a multidisciplinary team of doctors, pharmacists, chemists, and PhD holders working in more than 20 languages. Its proprietary product, PRUDENTA, is a cloud-based pharmacovigilance platform with artificial intelligence integration that supports local medical literature monitoring, validated search workflows, and electronic access to published articles for adverse drug reaction surveillance, and was developed with funding from an EU Commission grant (Agreement No. 828084).

The company generates revenue primarily through project-based professional services engagements and multi-year retainer contracts priced on scope and geographic coverage, with a secondary subscription/usage-based revenue stream from PRUDENTA. Go-to-market is enterprise field sales supported by active participation in major industry conferences (CPHI, RAPS, ISPE, TOPRA, DIA) and direct engagement via phone, email, and industry webinars. The firm has built an authorized partnership portfolio that includes LORENZ Life Sciences (eCTD and RIM solutions across 15 countries), DOT Compliance (AI-powered eQMS), and EPISTA Life Science (computer system validation software), allowing it to resell complementary technology alongside its consulting engagements. Inpharmatis reports 5,500+ completed projects and 500+ customers cumulatively, with no public revenue, funding, or valuation disclosure.

Inpharmatis firmographics

Firmographics
Name
Inpharmatis
Legal name
Inpharmatis SIA
Website
https://inpharmatis.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Inpharmatis is a Latvia-based international consulting group providing full-cycle regulatory affairs, pharmacovigilance, GMP/GDP auditing, eCTD publishing, and PIL readability testing to pharmaceutical, medical device, food supplement, cosmetic, and biotech companies across the EU, CIS, and EAEU.
Ownership category
akta.pro rank

Inpharmatis industry classification

Industry
Product category
Pharmaceutical Regulatory Consulting
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAJAK
Pharmacovigilance & Drug Safety Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

Keywords

  • Regulatory affairs consulting
  • Pharmacovigilance services
  • GMP GDP audits
  • ECTD publishing
  • Drug registration services

Where Inpharmatis is headquartered

Location

Headquarters

HQ city
Riga
HQ country
Latvia
HQ region
Europe

Offices3 records

Markets served

Inpharmatis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Regulatory Affairs Consulting Services: Professional consulting services for pharmaceutical product registration, dossier preparation, regulatory strategy development, and lifecycle management across EU, CIS, and EAEU markets. Revenue generated through project-based engagements and retainer arrangements.
  2. Pharmacovigilance Services: Full scope of pharmacovigilance consulting including QPPV/LPPV services, PSMF creation, case processing, literature monitoring, and signal management. Provided to pharmaceutical companies operating in regulated markets.
  3. Quality Management & GMP/GDP Audits: Consulting services for GMP/GDP compliance including pre-audits, inspection support, and QMS development. Sale of ready-made GMP audit reports of API manufacturers.
  4. eCTD Publishing Services: Electronic submission management and publishing services for regulatory dossiers. Handles dossier compilation, formatting, lifecycle management, and submission through regulatory portals.
  5. Training Services: In-house and customized training programs for regulatory affairs, pharmacovigilance, and GMP/GDP compliance. Offered as off-the-shelf, tailored, or bespoke programs.
  6. PIL Readability User Testing: User testing services for patient information leaflets according to EAEU requirements, including bridging studies and GAP analysis.
  7. PRUDENTA Software Solution: Cloud-based AI-powered solution for monitoring adverse drug reactions in local medical literature. Subscription or usage-based access to the platform.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Inpharmatis product offering

Product offering

Core offering

Inpharmatis is an international consulting group providing full-cycle pharmaceutical regulatory services including Regulatory Affairs, Pharmacovigilance, GMP/GDP audits, eCTD publishing, and training for pharmaceutical, biotech, medical device, food supplement, and cosmetic companies across EU, CIS, and EAEU markets. The company also develops PRUDENTA, a proprietary cloud-based AI-powered pharmacovigilance solution for local medical literature monitoring, funded by European Commission Grant Agreement No. 828084.

Product overview

Inpharmatis is an international consulting group providing full-cycle services in Regulatory Affairs, Pharmacovigilance, Quality Management (GMP/GDP), and electronic solutions for the Life Science industry. The company's service portfolio includes: Regulatory Affairs Services covering EU, CIS, and EAEU markets; Pharmacovigilance Services with QPPV/LPPV provision and literature monitoring; Quality Management & GMP/GDP Audits; eCTD Publishing Service; Training Programs; and PIL Readability User Testing. The company also offers PRUDENTA, a proprietary cloud-based pharmacovigilance solution with AI integration for local literature monitoring. Through strategic partnerships, Inpharmatis provides access to LORENZ eCTD/RIM solutions (docuBridge, drugTrack, eValidator), DOT Compliance AI-powered eQMS, and EPISTA validation software.

Differentiator

Problem solved

Functional benefit

Brands

  • PRUDENTA: Cloud-based pharmacovigilance solution for monitoring adverse drug reactions in local medical literature with AI integration and validated workflow processes.

Products and services

  • Regulatory Affairs Services Comprehensive consultancy services for registration of medicines, medical devices, food supplements, and cosmetics across Europe, CIS, and EAEU regions, including project management, regulatory strategy development, dossier preparation, and SmPC/PIL development for pharmaceutical companies.
  • Pharmacovigilance Services Full scope of pharmacovigilance consulting services including QPPV/LPPV provision, PV system creation and management, auditing, PSUR/RMP reports, signal management, and local medical literature monitoring in EU, CIS, and EAEU regions for pharmaceutical companies.
  • Quality Management & GMP/GDP Audits Quality management consulting services including QMS development, GMP/GDP consulting, QA services, QP services, GMP/GDP audits of manufacturers, and preparation for EU/EAEU inspections for pharmaceutical manufacturers.
  • eCTD Publishing Service Regulatory eCTD submission management and publishing services supporting full product lifecycle from initial submission to renewals and variations, with submissions handled to EMA, FDA, Swissmedic, Ukraine, MHRA, and EAEU.
  • Training Services In-house regulatory affairs, pharmacovigilance, and GMP/GDP training programs offered in off-the-shelf, tailored, and bespoke formats for pharmaceutical industry professionals.
  • PIL Readability User Testing Patient Information Leaflet (PIL) readability testing according to EAEU requirements with guaranteed acceptance rates, including GAP analysis, bridging studies, and translation services for pharmaceutical companies.
  • PRUDENTA Pharmacovigilance Platform Cloud-based AI-powered pharmacovigilance solution for monitoring adverse drug reactions in local medical literature, with electronic access to published articles, validated workflow processes, and quality control checks for pharmaceutical companies.

Quantifiable outcome

  • 5,500+ successfully completed projects
  • +3 more outcomes

Companies that use Inpharmatis

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Inpharmatis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Inpharmatis partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and supporting.

  • LORENZ Life Sciences GroupcoreTechnology or Integration · 28 May 2026Official LORENZ Partner authorised to promote and implement LORENZ eCTD and Regulatory Information Management (RIM) solutions including docuBridge, drugTrack, and eValidator in Turkey, Ukraine, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Uzbekistan, Turkmenistan, Mongolia, Latvia, Lithuania, and Estonia. LORENZ develops leading RIM solutions for Life Sciences since 1989 with over 1800 installations in 48 countries.
  • DOT CompliancecoreTechnology or IntegrationPartnership with DOT Compliance - the first ready-to-use AI-powered eQMS for Life Science Industry. Provides cloud-based quality management system solutions for rapid implementation and quality insights.
  • EPISTA Life SciencesupportingTechnology or IntegrationPartnership with EPISTA Life Science for software solutions that automate and accelerate validation of computer systems in the pharmaceutical industry.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Inpharmatis competitors and assessment

Company assessment

Broad incumbents

  • PharmaLex: PharmaLex is a larger, established regulatory affairs, pharmacovigilance, and quality management consultancy serving pharma and biotech globally. Direct overlap with Inpharmatis's full-service regulatory + PV + GMP offering, but at significantly greater scale and broader geographic footprint; recently acquired by Cencora, increasing competitive intensity.
  • CROMSOURCE: CROMSOURCE is an established mid-sized CRO providing clinical, regulatory, and pharmacovigilance services across Europe and emerging markets. Comparable EU + CIS service mix to Inpharmatis but with broader clinical CRO capabilities and larger headcount.

Direct peers

  • Arriello: Arriello is a regulatory affairs and pharmacovigilance consultancy with strong EU and emerging-markets presence, offering dossier preparation, local QPPV services, and PV operations. Closely comparable to Inpharmatis in service mix, customer profile (mid-market pharma), and multi-jurisdictional regulatory coverage.
  • Apcer Life Sciences: Apcer provides pharmacovigilance, regulatory affairs, and quality compliance services to pharma and medical device companies globally. Direct overlap with Inpharmatis in PV operations, regulatory consulting, and quality management services.
  • Pharmexon: Pharmexon is a regulatory affairs and pharmacovigilance consultancy supporting pharma clients across EU and international markets. Closely comparable boutique regulatory services model and similar target customer profile to Inpharmatis.
  • Regulis Consulting: Regulis is a regulatory affairs and pharmacovigilance consultancy providing EU and international market access services to pharma and biotech clients. Direct peer in service scope (registration, PV, QPPV) and customer segment.
  • Diapharm: Diapharm is a regulatory affairs, quality management, and pharmacovigilance consultancy focused on pharma, medical devices, and consumer health. Comparable boutique scale and EU-centric service portfolio with similar clientele to Inpharmatis.

Emerging players

  • PharmEng Technology: PharmEng Technology provides GMP compliance, validation, and regulatory consulting to pharma manufacturers. Overlaps with Inpharmatis's quality management and GMP/GDP audit services, particularly for API manufacturers seeking international registrations.

Others

  • DOT Compliance: DOT Compliance provides AI-powered electronic Quality Management System (eQMS) software for the life sciences industry. Technology partner of Inpharmatis for QMS implementations, with partial competitive overlap on quality management consulting.
  • LORENZ Life Sciences Group: LORENZ is a software vendor of eCTD and Regulatory Information Management (RIM) solutions used across life sciences. Inpharmatis is an authorized implementation partner for LORENZ, so this is a technology partner rather than competitor, but adjacent in the regulatory workflow Inpharmatis serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Inpharmatis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inpharmatis leadership team

Management profile

Number of profiles

Profiles7 records

Inpharmatis subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Inpharmatis funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inpharmatis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inpharmatis

What does Inpharmatis do?

Inpharmatis is an international consulting group providing full-cycle pharmaceutical regulatory services including Regulatory Affairs, Pharmacovigilance, GMP/GDP audits, eCTD publishing, and training for pharmaceutical, biotech, medical device, food supplement, and cosmetic companies across EU, CIS, and EAEU markets. The company also develops PRUDENTA, a proprietary cloud-based AI-powered pharmacovigilance solution for local medical literature monitoring, funded by European Commission Grant Agreement No. 828084.

Is Inpharmatis a public or private company?

Inpharmatis is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Inpharmatis founded?

Inpharmatis was founded in 2003. It employs 11 to 50 people.

Where is Inpharmatis based?

Inpharmatis is headquartered in Riga, Latvia, in the Europe region.

How does Inpharmatis make money?

Seven revenue lines are on record. Regulatory Affairs Consulting Services are the primary driver. The others are pharmacovigilance Services, quality Management & GMP/GDP Audits, eCTD Publishing Services, training Services, PIL Readability User Testing and PRUDENTA Software Solution.

Who are Inpharmatis's main competitors?

Broad incumbents on record are PharmaLex and CROMSOURCE. Direct peers are Arriello, Apcer Life Sciences, Pharmexon, Regulis Consulting and Diapharm. PharmEng Technology is listed as an emerging player. Others are DOT Compliance and LORENZ Life Sciences Group.

Does Inpharmatis have an API?

No public API is recorded for Inpharmatis.

What industry is Inpharmatis in?

Inpharmatis's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 54169 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales